Reply to Marakasova and Baranova, “MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection”
Guardado en:
Autores principales: | Jeffrey E. Gold, David J. Hurley, Balázs Rada, William H. Baumgartl, Larry P. Tilley, Warren E. Licht |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3b05e611f5034c68b66b7ba041668756 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Analysis of Measles-Mumps-Rubella (MMR) Titers of Recovered COVID-19 Patients
por: Jeffrey E. Gold, et al.
Publicado: (2020) -
MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection
por: Ekaterina Marakasova, et al.
Publicado: (2021) -
Vaksinasi Measles, Mumps, dan Rubella (MMR) Sebagai Prophylaxis Terhadap COVID-19
por: Sajuni Widjaja
Publicado: (2020) -
Determination of ELISA reactive mumps IgG antibodies in MMR vaccine recipients in comparison with MMR vaccine naive children: A cross sectional study
por: Gupta Riya, et al.
Publicado: (2021) -
Numerical optimization of three-cavity magneto mercury reciprocating (MMR) micropump
por: Ali Mehrabi, et al.
Publicado: (2021)